{"id":344764,"date":"2026-11-12T13:22:46","date_gmt":"2026-11-12T07:52:46","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=344764"},"modified":"2026-11-12T13:22:46","modified_gmt":"2026-11-12T07:52:46","slug":"pharmaceutical-company-tyres-maker-and-pipes-and-adhesives-maker-stocks-roadmap-sierra-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pharmaceutical-company-tyres-maker-and-pipes-and-adhesives-maker-stocks-roadmap-sierra-list\/","title":{"rendered":"3 Pharmaceutical Company, Tyres Maker and Pipes and Adhesives Maker Stocks With a Strong Future Roadmap: Ipca Laboratories, CEAT and Astral"},"content":{"rendered":"

Ipca Laboratories, CEAT and Astral: ROE of 11.5% to 14.2% and FY22 to FY26 revenue CAGR of 10.6% to 13.8%. Prices as of 11 Nov 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The three pharma, tyre and pipe stocks to watch are Ipca Laboratories, CEAT and Astral. Their return on equity ranges from 11.5% to 14.2%, and their revenue compound annual growth from FY22 to FY26 ranges from 10.6% to 13.8%. Ipca Laboratories has the highest return on equity at 14.2%, while CEAT has the fastest revenue growth at 13.8% a year. Prices are based on the 11 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n

Pharma, tyre and pipe stocks offer a focused view of a sector where demand keeps widening. Ipca Laboratories, CEAT and Astral cover a pharmaceutical company, a tyres maker and a pipes and adhesives maker.<\/p>\n

This list covers three pharma, tyre and pipe stocks with complete current figures: Ipca Laboratories, CEAT and Astral. Every figure comes from the latest reported financials and the 11 November 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n